Study on the Short-term Efficacy and Safety of Recombinant Human Thrombopoietin Combined With Immunosuppressant Sequential Eltrombopag Ethanolamine Dry Suspension in the Treatment of SAA/TD-NSAA
Clinical trial NCT07001397 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07001397
- Sponsor
- Peking Union Medical College Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-23
- Primary completion
- 2026-03-23
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.